CJC-1295 (no DAC) + Ipamorelin
1:1 Blend$79
$7.90 per mg
Size: 10mg
In stock
For Research Use Only. Not for human or veterinary use. Product strictly for laboratory research by qualified individuals. All sales are subject to our Terms & Conditions.
Prices are shown and charged in Canadian dollars (CAD).
Not from Canada? Your bank or payment provider will handle the exact exchange to your local currency automatically. Our currency switcher provides real-time USD estimates for reference only.
TrustLoop™
Partnership
We test, you test,
we reward.
Zero Risk
Protocol™
Purity guaranteed or your
money back. Full stop.
Complete Chain
of Custody
No dropshipping.
Full inventory control.
BATCH MATCHED
COAs
Every batch.
Every time.
cGMP & ISO 5
Benchmarks
Built for labs.
Grounded in protocol.
TrustLoop™
Partnership
We test, you test, we reward.
Zero Risk
Protocol™
Purity guaranteed or your money back.
Complete Chain
of Custody
No dropshipping. Full inventory control.
BATCH MATCHED
COAs
Every batch. Every time.
cGMP & ISO 5
Benchmarks
Built for labs. Grounded in protocol.
TrustLoop™
Partnership
We test and we reward.
Zero Risk
Protocol™
Money back guaruntee.
Complete Custody
Never dropshipped.
MATCHED
COAs
Every batch.
Every time.
cGMP & ISO 5
Benchmarks
Grounded in protocol.
CJC-1295 (no DAC) is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH) without the Drug Affinity Complex modification, producing a shorter, more pulsatile growth hormone release profile compared to its DAC counterpart. When combined with Ipamorelin, a selective growth hormone secretagogue and ghrelin receptor agonist, the blend targets two complementary and synergistic GH secretion pathways simultaneously, making it one of the most researched GHRH/GHRP combinations available to Canadian researchers today.
Researchers have investigated the CJC-1295 (no DAC) and Ipamorelin combination across a broad range of in vitro and in vivo models, with published studies exploring its role in amplifying pulsatile growth hormone secretion through dual receptor activation. CJC-1295 (no DAC) acts on pituitary GHRH receptors, while Ipamorelin selectively activates ghrelin receptors (GHS-R1a) without significantly stimulating cortisol, prolactin, or aldosterone secretion — a selectivity profile of particular interest to researchers studying clean GH secretagogue mechanisms. Published research has examined this combination in models relating to IGF-1 axis modulation, body composition, and sleep architecture.
This combination is frequently selected by Canadian researchers for its complementary dual-pathway mechanistic profile and is one of the most widely referenced GHRH/GHRP stacks in the preclinical research literature.
Ambros Labs supplies CJC-1295 (no DAC) + Ipamorelin to qualified researchers across Canada from our Canadian inventory. Every batch is independently tested by a third-party Canadian laboratory using HPLC and mass spectrometry, with verifiable Certificates of Analysis available for every batch. All orders ship same-day from Canada with full chain of custody documentation.
For research use only. Not for human or veterinary use. For use by qualified researchers in appropriate laboratory settings only.
CAS Number: 863288-34-0; 170851-70-4
Molecular Weight (g/moL): 3367.9; 711.9
Molecular Formula: C165H271N47O46; C38H49N9O5
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2; Aib-His-D-2-Nal-D-Phe-Lys-NH2
Format: White Lyophilized Powder
Purity: Exceeds 99% HPLC
Database Link:
